The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers

Food and Chemical Toxicology

Volumn 45, Issue 9, 2007, Pages 1593-1598

  McGilligan, V E ^a   Wallace, J M W ^a   Heavey, P M ^a   Ridley, D L ^a   Rowland, I R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Nicotine; Permeability; Tight junctions; Ulcerative colitis

Indexed keywords

ANATABINE; CLAUDIN 1; COTININE; FLUORESCEIN; NICOTINE DERIVATIVE; NICOTINE N' OXIDE; NICOTINE TARTRATE; NICOTYRINE; OCCLUDIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; FLUORESCEIN; FLUORESCENT DYES; GANGLIONIC STIMULANTS; HUMANS; INTESTINES; MEMBRANE PROTEINS; NICOTINE; PERMEABILITY; SMOKING; TIGHT JUNCTIONS;

EID: 34547115000     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.02.021     Document Type: Article

References (36)

1. Anderson J.G., and Van Italliae C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. American Journal of Physiology 269 (1995) G467-G475
2. Beaugerie L., Massot N., Carbonnel F., Catlan S., Gendre J.P., and Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. American Journal of Gastroenterology 96 (2001) 2113-2116
3. In: Benowitz N.L. (Ed). Nicotine Safety and Toxicity (1998), Oxford University Press, New York 1-20
4. Bose C., Zhang H., Udupa K.B., and Chowdbury P. Activation of p-ERK1/2 by nicotine in pancreatic tumour cell line AR42J: Effects on proliferation and secretion. American Journal of physiology and Gastrointestinal Liver Physiology (2005) G926-G934
5. Buisson B., and Bertrand D. Nicotine addiction: The possible role of functional upregulation. Journal of Pharmacological Sciences 23 (2002) 130-136
6. Calkins B.M. A meta analysis of the role of smoking in inflammatory bowel disease. Digestive Diseases and Sciences 29 (1988) 352-357
7. Chandran P., Satrthaporn S., Robins A., and Eremin O. Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (ii). Surgeon 1 (2003) 125-136
8. Clayburgh D.R., Shen L., and Turner J.R. A porous defense: The leaky epithelial barrier in intestinal disease. Laboratory Investigation 84 (2004) 282-291
9. Farrell J.R., and Peppercorn MA. Ulcerative Colitis. Lancet 359 (2002) 331-340
10. Gassler N., Rohr C., Schneider A., Kartenbeck J., Bach A., Obermuller N., Otto H.F., and Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. American Journal Physiology Gastrointestinal Liver Physiol 281 (2001) G216-G228
11. Gitter A.H., Wallstein F., Fromm M., and Schulzke J.D. Epithelial barrier defects in ulcerative colitis characterisation and quantification by electrophysiological imaging. Gastroenterology 121 (2001) 1320-1325
12. Gorrod J.W., and Jacob III. Analytical Determination of Nicotine and Related Compounds and their Metabolites (1999), Elsevier pp. 1-20
13. Harries A.D., Briad A., and Rhodes J. Non-smoking: A feature of ulcerative colitis. British Medical Journal 284 (1982) 706
14. Hawkins B.T., Abbruscato T.J., Egleton R.D., Brown R.C., Huber J.D., Campos C.R., and Davis T.P. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Research 1027 (2004) 48-58
15. Hollenbach E., Neumann M., Vieth M., Rossner A., Malfertheiner P., and Naumann M. Inhibition of p38 MAP kinase and RICK/NF-κB-signaling suppresses inflammatory bowel disease. Federation of American Societies for Experimental Biology 18 (2004) 1550-1552
16. Ingram J.R., Thomas G.A., Rhodes J., Green J.T., Hawkes N.D., Swift J.L., Srivastava E.D., Evans B.K., Williams G.T., Newcombe R.G., Courtney E., and Pillai S. A randomized trial of nicotine enemas for active ulcerative colitis. Clinical Gastroenterology and Hepatology 3 (2005) 1107-1114
17. Ingram J.B., Rhodes J., Evans B.K., and Thomas G.A.O. Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance. Inflammatory Bowel Disease 11 (2005) 1092-1096
18. Kinugassa Y., Sakaguchi Y., Gu X., and Reinecher H.C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118 (2000) 1001-1011
19. Kucharzik T., Walsh S.V., Chen J., Parkos C.A., and Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Gastroenterology 116 (1999) 301-309
20. Lockman P.R., Van der Schyf C.J., Abruscato T.J., and Allen D.D. Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. Journal of Neuroichemistry 94 (2005) 37-44
21. Ma T.Y., Iwanoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., and Said H.M. TNF alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. American Journal of Physiology and Gastrointestinal Liver Physiology 286 (2004) G367-G376
22. Motley R.J., Rhodes J., and Ford G.A. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 37 (1987) 125-127
23. McGrath J., McDonald J.W., and Macdonald J.K. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Systematic Reviews 18 (2004) CD004722
24. Nakayama H., Numakawa T., Ikeuchi T., and Hatanaka H. Nicotine-induced phosphorylation of extracellular signal-related protein kinase and CREB in PC12h cells. Journal of Neurochemistry 79 (2001) 489-498
25. Prytz H., Benoni C., and Tahesson C. Does smoking tighten the gut?. Scandinavian Journal of Gastroenterology 24 (1989) 1084-1088
26. Pullan R.D., Rhodes J., Ganesh S., Mani V., Morris J.S., Williams G.T., Newcombe R.G., Russell M., Feyerabend C., Thomas G., and Sawe U. Transdermal nicotine for active ulcerative colitis. New England Journal of Medicine 330 (1994) 811-815
27. Rudra Y., Motley R., and Rhodes J. Does smoking improve colitis?. Scandinavian Journal of Gastroenterology 24 (1989) 61-63
28. Sandborn W.J., Tremaine E.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., Croghan I.T., Dale L.C., Schroeder D.R., and Hurt R.D. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 126 (1997) 364-371
29. Sandborn W.J., Tremaine W.J., and Leighton J.A. Nicotine tartrate liquid enemas for mildly to moderately active left-sided UC unresponsive to first line therapy. A pilot study. Alimentary Pharmacology and Therapeutics 11 (1997) 663-671
30. Schmeltz I., and Hoffmann D. Nitrogen containing compounds in tobacco and tobacco smoke. Chemical Reviews 11 (1977) 295-311
31. Schmitz H., Barueyer C., Fromm M., Runkel N., Foss H.D., Bentzel C.J., Riecken E.O., and Schulzke J.D. Altered tight junction structure contributes to the impaired epithelial barrier function in UC. Gastroenterology 116 (1999) 301-309
32. Schulzke J.D., Gitter A.H., Mankertz J., Spiegel L.S., Seidler U., Amasheh L.S., Saitou M., Tsukita S.L., and Fromm M. Epithelial transport and barrier function in occludin deficient mice. Biochimica et biophysica acta 1669 (2005) 34-42
33. Suenaert P., Bulteel V., Den Hond E., Hiele M., Peeters M., Monsuur F., Ghoos Y., and Rutgeerts P. The effects of smoking and indometacin on small intestinal permeability. Alimentary Pharmacology and Therapeutics 14 (2000) 819-822
34. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Yousef A.A., Metz C., Miller E.J., Tracey K.J., and Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 10 (2004) 1216-1221
35. Ward P.D., Tippin T.K., and Thakker D.R. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharmaceutical Science and Technology Today (2000) 346-358
36. Watson J.P., and Lewis R.A. Ulcerative colitis: Responsive to smoking and to nicotine chewing gum in a patient with alpha 1 anti-trypsin deficiency. Respiratory Medicine 89 (1995) 635-636